KRT88P and hepatitis B virus infection: In Chakvetadze et al.’ study on HIV patients with anti-HBc and CD4 count above 200, they reported that one month after hepatitis B vaccination, 22% of participants showed anti-HBs titer above 10 IU/L, and the rest were identified as primary responders.